Trademark search for:

CLINDABEN

EXPIRED USPTO USPTO

No active United States Patent and Trademark Office (USPTO) registrations found, based on publicly available USPTO trademark records.

Trademark records may change over time. For the most up-to-date trademark status, domain availability, and social handle checks, run a live search.

Live search · Most up-to-date results

Also check across:

USPTO Filing History

Key events recorded for this trademark application

2001-07-28 — Application filed
2001-09-13 — Assigned to examiner
2001-10-04 — Final disposition recorded
2002-03-21 — Correspondence received in law office
2002-05-03 — Letter of suspension mailed
2003-04-03 — Paper received
2003-04-03 — Correspondence received in law office
2003-05-26 — Approved for pub - principal register
2003-07-09 — Notice of publication
2003-07-29 — Published for opposition
2003-10-21 — Registered-principal register
2008-07-30 — Case file in ticrs
2009-12-10 — Attorney/dom.rep.revoked and/or appointed
2009-12-10 — Teas revoke/app/change addr of atty/dom rep received
2010-05-29 — Cancelled sec. 8 (6-yr)
2010-05-29 — Final status recorded
2011-03-23 — Assignment of ownership not updated automatically

Owner Information

DOW PHARMACEUTICAL SCIENCES, INC.
PETALUMA , CA

DERMAL LABORATORIES, INC.
PETALUMA , CA

Clindaben Limited
London GB

Correspondent

Matthew Marshall Valeant Pharmaceuticals North America
1 Enterprise
Legal Dept.
Aliso Viejo, CA 92656

Filing Details

Filing Date:
2001-07-28

Status Date:
2010-05-29

Category:
Pharmaceuticals

Filing Year:
1991

Disclaimer: This page is informational only and does not constitute legal advice. Trademark availability depends on jurisdiction, usage, and legal interpretation.